Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation
March 16, 2020Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma
As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …
FDA greenlights Celltrion HIV drug manufacturing facility in South Korea
March 16, 2020Manufacturing and Production, Sales and Marketing FDA, celltrion, coronavirus, pharma
South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …
Numerous sporting events suspended across the UK, after staff and players test positive for COVID-19
March 13, 2020Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus
Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …
AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer
March 13, 2020Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure
Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …
Top Ten most popular articles on Pharmafile.com this week
March 13, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus
HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …
Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia
March 13, 2020Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma
The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …
UK Government criticised for not enacting social distancing measures to combat coronavirus
March 13, 2020Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus
The UK government has come under fire from health experts and former cabinet ministers for its strategy in fighting the …
Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund
March 12, 2020Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …
Iran foreign ministry accuses US of blocking medicine deliveries
March 12, 2020Business Services Iran, Iran Trump, Trump Iran
A spokesperson from the Iranian foreign ministry has accused the US of refusing to deliver medicine to the country. US …
Trump suspends all travel from Europe to US as coronavirus continues to spread
March 12, 2020Business Services American coronavirus, Chinese Coronavirus, UK Coronavirus, US Coronavirus, Wuhan Coronavirus, wuhan coronavirus.
Last night, President Donald Trump announced significant measures to deal with the increasing threat of the coronavirus. From Friday, the …
Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine
March 12, 2020Sales and Marketing NICE, Teva, ajovy, migraine, pharma
NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …
Bristol-Myers Squibb liver cancer drug combo gets FDA approval
March 12, 2020Business Services Bristol; Myer Squibb, FDA, FDA BSM, FDA approvals
The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …
FDA halts overseas inspections over coronavirus concerns
March 11, 2020Research and Development, Sales and Marketing FDA, US, approvals, pharma
The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …
Ameluz approved by European Commission for treatment for actinic keratosis
March 11, 2020Research and Development EC, EMA, Europe, Lesions
Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma
March 11, 2020Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma
Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …
A man from London becomes second person to be cured of HIV
March 11, 2020Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV
Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …
Data science firm Genomics Plc names new Chief Strategy Officer
March 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma
Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …
The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns
March 10, 2020Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology
The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …
Boehringer’s TKI inhibitor Ofev gets FDA approval for chronic fibrosing interstitial lung diseases with a progressive phenotype
March 10, 2020Manufacturing and Production, Sales and Marketing Boehringer, FDA, ofev, pharma
The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing interstitial lung …
Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women
March 10, 2020Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin
Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
